Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1994-7-25
pubmed:abstractText
1. In mouse pancreatic beta-cells the role of cytosolic nucleotides in the regulation of the sulphonylurea sensitivity of the adenosine 5'-triphosphate-sensitive K+ channel (KATP-channel) was examined. Patch-clamp experiments with excised inside-out membrane patches were carried out using an experimental protocol favouring phosphorylation of membrane proteins. 2. In the absence of Mg2+, the KATP-channel-inhibiting potency of cytosolic nucleotides decreased in the order ATP = adenosine 5'-O-(3-thiotriphosphate) (ATP gamma S) > adenosine 5'-diphosphate (ADP) > adenosine 5'-O-(2-thiodiphosphate) (ADP beta S) = adenylyl-imidodiphosphate (AMP-PNP) > 2'-deoxyadenosine 5'-triphosphate (dATP) > uridine 5'-triphosphate (UTP) > 2'-deoxyadenosine 5'-diphosphate (dADP) > guanosine 5'-triphosphate (GTP) > guanosine 5'-diphosphate (GDP) > uridine 5'-diphosphate (UDP). 3. In the presence of Mg2+, the inhibitory potency of cytosolic nucleotides decreased in the order ATP gamma S > ATP > AMP-PNP > ADP beta S > dATP > UTP. In the presence of Mg2+, the KATP-channels were activated by dADP, GTP, GDP and UDP. 4. Tolbutamide inhibited the KATP-channels not only in the presence but also in the prolonged absence of Mg2+. In nucleotide-free solutions, the potency of tolbutamide was very low. When about half of the KATP-channel activity was inhibited by ATP, AMP-PNP, ADP beta S or ADP (absence of Mg2+), the potency of tolbutamide was increased. 5. Tolbutamide (100 microM) slightly enhanced the channel-inhibiting potency of AMP-PNP and inhibited the channel-activating effect of MgGDP in a non-competitive manner. 6. Channel activation by MgGDP (0.5 mM) competitively antagonized the inhibitory responses to AMP-PNP (1 MicroM- 1 mM). This effect of GDP was neutralized by tolbutamide (100 MicroM).7. The stimulatory effect of 0.5 mM MgGDP was neutralized by 200 MicroM AMP-PNP. Under these conditions the potency of tolbutamide was much higher than in the presence of 0.5 mM MgGDP alone or in the absence of any nucleotides.8. dADP (0.3-1 mM) increased the potency of tolbutamide. Additional application of 200 MicroM AMPPNP caused a further increase in the potency of tolbutamide.9. In conclusion, in the simultaneous presence of inhibitory and stimulatory nucleotides, binding of sulphonylureas to their receptor causes direct inhibition of channel activity, non-competitive inhibition of the action of stimulatory nucleotides and interruption of the competitive interaction between stimulatory and inhibitory nucleotides. The latter effect increases the proportion of KATP- channels staying in the nucleotide-blocked state. In addition, this state potentiates the direct effect of sulphonylureas.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-1393263, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-1422577, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-1422580, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-1478610, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-1482696, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-1501109, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-1676517, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-1706203, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-1890633, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-1903188, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-1974057, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-2090953, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-2412077, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-2431383, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-2436138, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-2442362, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-2484976, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-2514595, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-2621629, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-2650685, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-2666156, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-2676059, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-2691645, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-3053250, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-3146398, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-3231093, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-6090930, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-6095103, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-6270629, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-6296371, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-6334536, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-6386515, http://linkedlifedata.com/resource/pubmed/commentcorrection/8012711-8246187
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
111
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
302-10
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1994
pubmed:articleTitle
Interaction of tolbutamide and cytosolic nucleotides in controlling the ATP-sensitive K+ channel in mouse beta-cells.
pubmed:affiliation
Institute of Pharmacology & Toxicology, University of Göttingen, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't